$270 Million is the total value of Monashee Investment Management LLC's 52 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 72.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | Sell | VANGUARD TOTAL STOCK MKT ETFtotal stk mkt | $85,069,000 | -62.3% | 474,000 | -60.4% | 31.55% | -61.6% |
| DYN | Sell | DYNE THERAPEUTICS INC | $2,540,000 | +15.7% | 200,000 | -37.4% | 0.94% | +17.9% |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $1,868,000 | -55.5% | 95,000 | -60.4% | 0.69% | -54.6% |
| Sell | DOCGO INC | $1,736,000 | -36.8% | 175,000 | -54.6% | 0.64% | -35.7% | |
| Sell | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $1,489,000 | +41.8% | 191,945 | -4.0% | 0.55% | +44.5% | |
| Sell | 2SEVENTY BIO INC | $1,019,000 | -3.5% | 70,000 | -12.5% | 0.38% | -1.6% | |
| Exit | IVANHOE ELECTRIC INC / US | $0 | – | -25,246 | -100.0% | -0.08% | – | |
| ASPN | Exit | ASPEN AEROGELS INC | $0 | – | -37,500 | -100.0% | -0.14% | – |
| LU | Exit | LUFAX HOLDING LTD-ADR | $0 | – | -85,000 | -100.0% | -0.19% | – |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -30,000 | -100.0% | -0.20% | – |
| EBR | Exit | CENTRAIS ELETRICAS BR-SP ADRsponsored adr | $0 | – | -100,030 | -100.0% | -0.32% | – |
| Exit | REVELATION BIOSCIENCES INC | $0 | – | -817,562 | -100.0% | -0.33% | – | |
| Exit | EUROPEAN WAX CENTER INC-A | $0 | – | -67,000 | -100.0% | -0.43% | – | |
| GLPI | Exit | GAMING AND LEISURE PROPERTIE | $0 | – | -33,908 | -100.0% | -0.57% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -45,000 | -100.0% | -0.64% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -95,000 | -100.0% | -0.64% | – |
| Exit | ARCELLX INC | $0 | – | -122,129 | -100.0% | -0.80% | – | |
| VIEW | Exit | VIEW INC | $0 | – | -1,500,000 | -100.0% | -0.88% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -85,000 | -100.0% | -0.94% | – |
| ACI | Exit | ALBERTSONS COS INC | $0 | – | -125,000 | -100.0% | -1.22% | – |
| AMT | Exit | AMERICAN TOWER CORP | $0 | – | -15,000 | -100.0% | -1.40% | – |
| Exit | HYPERFINE INC | $0 | – | -1,742,490 | -100.0% | -1.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.3% |
| VANGUARD TOTAL STOCK MKT ETF | 12 | Q2 2023 | 82.1% |
| SOMALOGIC INC | 9 | Q3 2023 | 3.4% |
| BIONANO GENOMICS INC | 9 | Q4 2020 | 0.1% |
| COMPASS THERAPEUTICS INC | 8 | Q3 2023 | 4.8% |
| BIOMX INC | 8 | Q3 2021 | 0.0% |
| AN2 THERAPEUTICS INC | 7 | Q3 2023 | 1.9% |
| COLLIER CREEK HOLDINGS | 7 | Q2 2020 | 0.3% |
| WHOLE EARTH BRANDS INC | 7 | Q4 2021 | 0.2% |
| FINTECH ACQUISITION CORP III | 7 | Q3 2020 | 0.2% |
View Monashee Investment Management LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-07 |
View Monashee Investment Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.